Navigation Links
Helix Bioscience Appointed DNA Drug Sensitivity Testing Distributor for Genelex Corporation
Date:7/14/2010

SEATTLE and TULSA, Okla., July 14 /PRNewswire/ -- Genelex and Helix have announced a personalized prescribing strategic alliance to increase the availability of important new DNA Drug Sensitivity Tests such as Plavitest™ and Tamoxitest™. These tests and the GeneMedRx medication management software can save lives and healthcare dollars by allowing doctors to personalize their prescribing practices in order to prevent adverse medication outcomes, including treatment failures and dangerous side effects.

"Helix's knowledge and experience make them ideally suited to expand access to these products and contribute to improving prescribing safety," said Howard Coleman, Genelex Chief Executive Officer.

Helix is concentrating its initial efforts on Plavitest™ due to the recent FDA boxed warning placed on Plavix. Recent clinical research demonstrates that approximately one-third of patients are in varying degrees of treatment failure and could be at an increased risk of a recurrent heart attack, stroke or cardiovascular death. Plavitest identifies these patients so doctors can improve their medication regimen and chances for successful treatment. Plavix is the second leading selling prescription drug with over $8 billion in worldwide annual sales.

"We chose Genelex as our laboratory partner because of its proven track record in delivering DNA Drug Sensitivity Tests and the advantage of the GeneMedRx interpretive software," said Lincoln Maxwell, Helix chief executive officer. GeneMedRx closes the "interpretation gap" by providing prescribers actionable information to reduce the risk of treatment failures and adverse reactions based on the genetics and overall medication regimen of patients.

Helix Biosciences is a new company formed by a team of diagnostic industry professionals to bring the benefits of genetic testing to doctors and their patients.

Genelex (jen-uh-LEX) sells a combination of DNA Drug Sensitivity Testing and the GeneMedRx (jeen-med-r-x) software to doctors to help them choose the safest, most effective medicines for their patients. Wide adoption of these technologies is aimed at dramatically reduce deaths and injuries from adverse drug reactions, interactions and treatment failure.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Howard Coleman

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=44528


'/>"/>
SOURCE Genelex
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Helix BioPharma Reports On 2009 Annual General Meeting
2. Helix BioPharma Corp. Announces Fiscal Q1 2010 Results
3. Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts
4. Helix BioPharma Corp. Announces Fiscal 2009 Results
5. Helix BioPharma Provides Updates on Topical Interferon Alpha-2b and L-DOS47 Following Pre-IND Meetings With the U.S. FDA
6. J. Craig Venter, Ph.D. Receives Double Helix Medal from Cold Spring Harbor Laboratory
7. Helix Receives Approval to Open Sites in Germany for its Ongoing Clinical Trial With Topical Interferon Alpha-2b in Patients With Ano-Genital Warts
8. Award Winning Mayo Clinic Scientist Joins Cardio3 BioSciences
9. SeqWrights Partnership with EraGen Biosciences Contributes to FDA Market Clearance Success
10. Signum Biosciences, Inc. Announces Commercial Launch of Arazine™
11. Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant Human Stem Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/10/2017)... , May 10, 2017  The Corporate Whistleblower ... employees of sleep therapy clinics to call us ... therapy clinic is involved in a substantial scheme ... in hearing from an employee of a medical ... a kickback scheme to provide medical practice groups with ...
(Date:5/10/2017)... 10, 2017 CSSi, the global leader in ... research industry, is proud to announce the launch of ... website features both enriched content and a customized layout ... the company,s already well-established position as the top global ... "After many months of hard work, we are delighted ...
(Date:5/9/2017)... 9, 2017  Demonstrating its commitment to representing ... for the Pharmaceutical Research and Manufacturers of America ... companies will now have to meet new research ... eligible to join PhRMA. "By putting ... sending a clear message that being a member ...
Breaking Medicine Technology:
(Date:5/26/2017)... ... ... Rob Lowe acts as host and helps educate and inform the public using the ... can reconnect with America as it explores some of the best places to hike ... an inventive new place for a family vacation, and have discovered hiking. Many will ...
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... “THE FLINTHILLS FAMILY-Our Journey to the Cross”: ... FAMILY-Our Journey to the Cross” is the creation of published authors, Bob and Margaret Massey. ... used to say, he is "panther quick and leather tough." His love for others ...
(Date:5/26/2017)... ... May 26, 2017 , ... “Cactus Jack: Against All Odds”: ... many others. “Cactus Jack: Against All Odds” is the creation of published author, ... Hubbard is married to Jack Carlisle’s third child Jane. Walter. Walter and Jane ...
(Date:5/24/2017)... ... May 24, 2017 , ... In modern research, ... most appropriate instruments for research and understanding the basic principles that were designed ... focus on innovations in stereo microscopy for brightfield and fluorescence typically used in ...
(Date:5/24/2017)... San Diego, California (PRWEB) , ... May 24, ... ... patient care through innovative medical image management and interpretation, has received U.S. Food ... technology. , Nucleus.io is a web-based, scalable and secure cloud platform for ...
Breaking Medicine News(10 mins):